Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin/Glimepiride Combination vs Monotherapy in T2DM
NCT00941161Phase 4Completed
- Sponsor
- Laboratorios Silanes
- Start
- Feb 2009
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Metformin/Glimepiride, Metformin and Glimepiride (3 arms). Primary endpoints: Hemoglobin A1c at 3 months and Fasting Plasma Glucose at 3 months. Started Feb 2009; status: completed.
02
Drugs
metforminglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00941161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941161.